Medical devices, healthcare technology and the business of care
PMA approval · P200037

ASSURE Wearable Cardioverter Defibrillator (WCD) System

Kestra Medical Technologies, Inc. · Decision date Jul 27, 2021

MEDTECHLEDGER EXPLANATIONP200037

What did the FDA approve?

FDA PMA P200037 records an approval for the ASSURE Wearable Cardioverter Defibrillator (WCD) System on 2021-07-27. The supplied database fields identify the device category as a wearable automated external defibrillator, product code MVK, with Kestra Medical Technologies, Inc. as applicant.

The statement gives the approved use in plain English: adult patients at risk for sudden cardiac arrest who are not candidates for, or refuse, an implantable defibrillator. It does not describe any supplement, manufacturing change, or separate original PMA scope beyond that labeled approval statement, so no further technical change can be inferred from the source text.

FDA approval order statement

Approval for the ASSURE system which is indicated for adult patients who are at risk for sudden cardiac arrest and are not candidates for, or refuse, an implantable defibrillator.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Jul 27, 2021

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P200037
Regulatory pathway
Premarket approval application
Product code
MVK
Decision code
APPR
Decision date
Jul 27, 2021
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Wearable automated external defibrillator.

Product code
MVK
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P200037 received

    Application receipt date recorded by FDA.

  2. P200037 · FDA decision

    APPR

  3. P200037/S021 · Related supplement

    ASSURE Wearable Cardioverter Defibrillator (WCD) System

  4. P200037/S022 · Related supplement

    ASSURE Wearable Cardioverter Defibrillator (WCD) System

Timeline entries are records held by MedtechLedger for P200037. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P200037

Product / regulatory recordCompanyPathwayDecision dateSource
Kestra Medical Technologies, Inc.PMA supplementSep 28, 2026FDA
Kestra Medical Technologies, Inc.PMA supplementNov 4, 2026FDA

Explore the linked device profile

Other records with product code MVK

Product / regulatory recordCompanyPathwayDecision dateSource
Zoll Manufacturing CorporationPMA supplementOct 6, 2026FDA
Zoll Manufacturing CorporationPMA supplementOct 5, 2026FDA
Zoll Manufacturing CorporationPMA supplementSep 29, 2026FDA
Zoll Manufacturing CorporationPMA supplementSep 9, 2026FDA
Zoll Manufacturing CorporationPMA approvalDec 18, 2001FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Kestra Medical Technologies, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
3933 Lake Washington Blvd. NE, Suite 200, Kirkland, WA, 98033

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records